financetom
Business
financetom
/
Business
/
Joby Aviation Insider Sold Shares Worth $329,630, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Joby Aviation Insider Sold Shares Worth $329,630, According to a Recent SEC Filing
Jul 15, 2025 2:54 PM

05:29 PM EDT, 07/15/2025 (MT Newswires) -- Eric Allison, Chief Product Officer, on July 12, 2025, sold 27,538 shares in Joby Aviation ( JOBY ) for $329,630. Following the Form 4 filing with the SEC, Allison has control over a total of 660,076 common shares of the company, with 660,076 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1819848/000181984825000466/xslF345X05/wk-form4_1752614659.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Nkarta Posts Narrower Q4 Loss; Discloses Restructuring Plan
Nkarta Posts Narrower Q4 Loss; Discloses Restructuring Plan
Mar 26, 2025
05:24 PM EDT, 03/26/2025 (MT Newswires) -- Nkarta ( NKTX ) late Wednesday reported a Q4 loss of $0.35 per diluted share, compared with a $0.57 loss a year earlier. Four analysts polled by FactSet expected a $0.43 loss. As expected, the company reported no revenue for the quarter ended Dec. 31. Nkarta ( NKTX ) also disclosed plans for...
FirstEnergy to Cut Workforce Amid Organizational Changes
FirstEnergy to Cut Workforce Amid Organizational Changes
Mar 26, 2025
05:26 PM EDT, 03/26/2025 (MT Newswires) -- FirstEnergy ( FE ) said Wednesday that it is reducing its workforce by less than 3% as part of organizational changes. The company also said about 200 employees will be reassigned with the changes. ...
US FDA greenlights first-ever treatment for rare genetic disorder
US FDA greenlights first-ever treatment for rare genetic disorder
Mar 26, 2025
March 26 (Reuters) - The U.S. Food and Drug Administration approved Soleno Therapeutics' ( SLNO ) drug to treat a rare genetic disorder on Wednesday, making it the first treatment available for patients who experience feelings of intense and persistent hunger. Shares of the company were halted for trading. The drug, branded as Vykat XR, received FDA's approval to treat...
Cno Financial Group Insider Sold Shares Worth $429,826, According to a Recent SEC Filing
Cno Financial Group Insider Sold Shares Worth $429,826, According to a Recent SEC Filing
Mar 26, 2025
05:32 PM EDT, 03/26/2025 (MT Newswires) -- Yvonne K Franzese, Chief Human Resources Officer, on March 24, 2025, sold 10,206 shares in Cno Financial Group ( CNO ) for $429,826. Following the Form 4 filing with the SEC, Franzese has control over a total of 106,223 common shares of the company, with 30,321 shares held directly and 75,902 controlled indirectly....
Copyright 2023-2026 - www.financetom.com All Rights Reserved